摘要 ：统计22家国内上市仪器公司2025年业绩预告数据，拆解各企业业绩变动核心原因，剖析行业发展现状与趋势，为 市场参与者提供参考。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 2026 年初以来，国内仪器行业上市企业陆续披露 2025 年业绩预告，行业整体经营态势逐步清晰。本文对 统计到的 22 家国产仪器厂商业绩预告进行系统梳理，涵盖多个细分领域， 为市场参与者提供参考。 从净利润来看， 共有11家企业盈利，11家企业亏损；与上年同期相比，盈利企业中8家实现同比增长，3家 盈利但增速平缓或略有波动，亏损企业中4家实现亏损收窄，7家出现亏损扩大或由盈转亏。 可以看出，在 国内下游需求波动、行业竞争持续加剧、政策环境调整及全球供应链不稳定的多重背景下，国产仪器行业业 绩分化态势进一步加剧，部分企业凭借前瞻性的战略布局实现增长，展现出强劲的经营韧性，而部分企业则 受困于业务转型、资产减值等因素，面临阶段性经营压力。 埃 科 光 电 | | | 2025年度国产仪器上市企业净利润统计表 | | | | --- | --- | --- | ...

证券日报网讯2月4日，理邦仪器（300206）在互动平台回答投资者提问时表示，截至2026年1月9日，理 邦仪器股东人数为24236户。 ...

证券日报网讯2月4日，理邦仪器（300206）在互动平台回答投资者提问时表示，截至2026年1月30日， 公司股东人数为24106户。 ...

Core Viewpoint - The company, Edan Instruments, forecasts a net profit attributable to shareholders of 284 million to 332 million yuan for 2025, representing a year-on-year growth of 75% to 105% [1] Group 1: Financial Performance - The company expects steady growth in overall revenue for 2025, particularly in international markets, which are projected to maintain double-digit growth [1] - Non-recurring gains and losses are anticipated to impact net profit by approximately 14 million yuan, mainly from government subsidies, which is a decrease of around 4 million yuan compared to the previous year [1] Group 2: Business Strategy - The company continues to focus on its development strategy of "innovation, platform-based, and internationalization," enhancing its global business layout and service capabilities in overseas markets [1] - Edan Instruments is accelerating new product development and optimizing its marketing system while advancing its overseas manufacturing strategy [2] - The company has been collaborating with the Gates Foundation, with progress on handheld ultrasound devices reaching clinical validation and confirmation stages [2] Group 3: Operational Developments - A new facility in the U.S. covering 1,940 square meters has been added to enhance the company's business layout in North America and improve supply chain resilience [2] - The new facility has received comprehensive certifications, including MDSAP certification and the California FDB medical device production license [2] - The company plans to flexibly arrange domestic and overseas production capacity based on order demand after the new U.S. facility is operational, which is expected to enhance profitability in the long term [3]

理邦仪器1月19日公告，预计2025年度归母净利润2.84亿元-3.32亿元，同比增长75%-105%。 ...

Core Viewpoint - The company, Libang Instruments, forecasts a significant increase in net profit for the year 2025, expecting a rise of over 50% compared to the previous year [2]. Financial Performance - The net profit attributable to shareholders for the current reporting period is projected to be 28,369.15 million, representing a 75% increase compared to the same period last year, which was 16,210.94 million [3]. - The net profit after deducting non-recurring gains and losses is expected to be 27,294.31 million, reflecting a 90% increase from the previous year's 14,365.43 million [3]. Reasons for Performance Changes - The company has been focusing on an "innovative, platform-based, and international" development strategy, leading to steady growth in overall revenue, particularly in international markets, which have shown double-digit growth, especially in patient monitoring and ultrasound imaging [4]. - The company has improved its operational management and reduced marketing and R&D expenses effectively, aligning with its goal of enhancing quality and efficiency [4]. - Non-recurring gains and losses are expected to impact net profit by approximately 14 million, primarily from government subsidies, which have decreased by around 4 million compared to the previous year [4].

Core Viewpoint - The company expects a significant increase in net profit for the fiscal year 2025, driven by growth in overseas markets and specific business segments [1] Financial Performance - The projected net profit attributable to shareholders for 2025 is estimated to be between 284 million to 332 million yuan, representing a growth of 75.00% to 105.00% compared to the previous year [1] - The net profit after deducting non-recurring gains and losses is expected to be between 273 million to 316 million yuan, with a growth range of 90.00% to 120.00% [1] Business Growth Drivers - The announcement highlights that the growth in performance is primarily due to steady progress in overseas markets and significant growth in patient monitoring and ultrasound imaging businesses [1] Non-Recurring Gains - The impact of non-recurring gains and losses on net profit is anticipated to be 14 million yuan, mainly from government subsidies, which is a decrease of 4 million yuan compared to the previous year [1]

Core Viewpoint - The stock price of Libang Instruments has surged by 10.88%, with a trading volume of 5.8983 million shares and a transaction amount of 94.142 million yuan, following the release of its latest earnings forecast for 2025, which indicates a projected net profit of 284 million to 332 million yuan, representing a year-on-year growth of 75% to 105% [2] Group 1 - Libang Instruments' stock price increased significantly, reflecting strong market performance [2] - The company anticipates a substantial rise in net profit for 2025, with projections indicating a growth range of 75% to 105% [2] - Other companies that released earnings forecasts today, such as Huace Testing, Mingtai Aluminum, and ST Yuanzhi, also experienced stock price increases of 10.78%, 8.86%, and 5.07% respectively [2] Group 2 - Despite the stock price surge, the main funds for Libang Instruments have shown a net outflow of 66.9876 million yuan over the past five days, with a net outflow of 9.3593 million yuan on the previous trading day [2]

Group 1: Economic Outlook - The International Monetary Fund (IMF) has raised China's economic growth forecast for 2025 by 0.2 percentage points to 5% and has also upgraded the 2026 growth expectations [3] Group 2: Government Announcements - The State Council Information Office will hold two press conferences on January 20, focusing on the implementation of the Central Economic Work Conference and the role of proactive fiscal policy in promoting high-quality economic development [3] - A press conference on January 21 will discuss the achievements in industrial and information technology development by 2025 [3] Group 3: Regulatory Developments - The Civil Aviation Administration of China introduced a revised Civil Aviation Law, encouraging the development of general aviation and establishing a supportive infrastructure network [4] Group 4: Company News - Yidian Tianxia will resume trading on January 20, not involving GEO business [7] - Tianjian Technology may face delisting risk warnings [7] - Huichuan Technology plans to issue H-shares and list on the Hong Kong Stock Exchange [7] - Far East Transmission expects a net profit increase of 25.06% to 41.96% in 2025 [7] - Guilin Tourism anticipates a profit of 11 million yuan in 2025, reversing losses [7] - ST Yuanzhi forecasts a net profit increase of 396.77% to 507.16% in 2025 [7] - Runfeng Co. expects a net profit increase of 128.85% to 159.95% in 2025 [8] - Xiangcai Securities anticipates a net profit of 553 million yuan in 2025, a 157% increase [8] - Haoshanghao expects a net profit increase of 115.64% to 175.35% in 2025 [8] - Hunan Yuneng forecasts a net profit increase of 93.75% to 135.87% in 2025 [8] - Libang Instruments expects a net profit increase of 75% to 105% in 2025 [8] - Chengdu Huamei anticipates a net profit increase of 74.35% to 108.73% in 2025 [8] - Jihong Co. expects a net profit increase of 50% to 60% in 2025 [8] - Guotou Securities anticipates a net profit of 3.4 billion yuan in 2025, a growth of over 35% [8] - Dinglong Co. expects a net profit increase of 34.44% to 40.2% in 2025 [8] - Ruimaite anticipates a net profit increase of 22.28% to 51.24% in 2025 [8] - Nanfang Energy expects a profit of 300 million to 360 million yuan in 2025, reversing losses [8] - Xianglu Tungsten Industry anticipates a profit of 125 million to 180 million yuan in 2025, reversing losses [8] - Feiwo Technology expects a profit of 32 million to 45 million yuan in 2025, reversing losses [8] - Yitong Century anticipates a profit of 8 million to 12 million yuan in 2025, reversing losses [8] - A controlling shareholder of Aotai Bio has proposed a share buyback of 100 million to 200 million yuan [8]

Key Points - The International Monetary Fund (IMF) has raised China's economic growth forecast for 2025 by 0.2 percentage points to 5% and has also adjusted the growth expectations for 2026 [3] - The National Development and Reform Commission will hold a press conference on January 20 to discuss the implementation of the central economic work conference and the "14th Five-Year Plan" [3] - The Ministry of Finance will also hold a press conference on the same day to discuss the role of proactive fiscal policy in promoting high-quality economic and social development [3] - The Supreme People's Procuratorate has emphasized the need to use legal power to support high-quality development and maintain economic and financial security [3] - The Civil Aviation Administration of China has introduced a new Civil Aviation Law that encourages the development of general aviation and aims to create a supportive infrastructure network [4] - There are rumors about the existence of fake accounts participating in Hong Kong stock IPOs, which have been dismissed as unfounded by market experts [5] - The Loan Prime Rate (LPR) is set to be adjusted on January 20, with the current 1-year LPR at 3% and the 5-year LPR at 3.5% [5] Company News - Yidian Tianxia will resume trading on January 20, not involving GEO business [7] - Tianjian Technology may face delisting risk due to trading issues [7] - Huichuan Technology is planning to issue H-shares and list on the Hong Kong Stock Exchange [7] - Far East Transmission expects a net profit increase of 25.06% to 41.96% in 2025 [7] - Guilin Tourism anticipates a profit of 11 million yuan in 2025, marking a turnaround [7] - ST Yuanzhi expects a net profit increase of 396.77% to 507.16% in 2025 [7] - Runfeng Co. anticipates a net profit increase of 128.85% to 159.95% in 2025 [7] - Xiangcai Securities expects a net profit of 553 million yuan in 2025, a 157% increase [7] - Haoshanghao expects a net profit increase of 115.64% to 175.35% in 2025 [7] - Hunan Yuneng anticipates a net profit increase of 93.75% to 135.87% in 2025 [7] - Libang Instruments expects a net profit increase of 75% to 105% in 2025 [7] - Chengdu Huamei anticipates a net profit increase of 74.35% to 108.73% in 2025 [7] - Jihong Co. expects a net profit increase of 50% to 60% in 2025 [7] - Guotou Securities expects a net profit of 3.4 billion yuan in 2025, a growth of over 35% [8] - Dinglong Co. anticipates a net profit increase of 34.44% to 40.2% in 2025 [8] - Ruimaite expects a net profit increase of 22.28% to 51.24% in 2025 [8] - Nanfang Energy expects a profit of 300 million to 360 million yuan in 2025, marking a turnaround [8] - Xianglu Tungsten Industry expects a profit of 125 million to 180 million yuan in 2025, marking a turnaround [8] - Feiwo Technology expects a profit of 32 million to 45 million yuan in 2025, marking a turnaround [8] - Yitong Century expects a profit of 8 million to 12 million yuan in 2025, marking a turnaround [8] - Aotai Bio's controlling shareholder has proposed a share buyback of 100 million to 200 million yuan [8]